Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4859606
Max Phase: Preclinical
Molecular Formula: C35H39IN4OS
Molecular Weight: 563.79
Molecule Type: Unknown
Associated Items:
ID: ALA4859606
Max Phase: Preclinical
Molecular Formula: C35H39IN4OS
Molecular Weight: 563.79
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)c1ccc(/C=C/c2cc(/C=C3\Sc4ccccc4N3CCCN3CCOCC3)c3ccccc3[n+]2C)cc1.[I-]
Standard InChI: InChI=1S/C35H39N4OS.HI/c1-36(2)29-16-13-27(14-17-29)15-18-30-25-28(31-9-4-5-10-32(31)37(30)3)26-35-39(33-11-6-7-12-34(33)41-35)20-8-19-38-21-23-40-24-22-38;/h4-7,9-18,25-26H,8,19-24H2,1-3H3;1H/q+1;/p-1
Standard InChI Key: GWKIKXZINVGPPC-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 563.79 | Molecular Weight (Monoisotopic): 563.2839 | AlogP: 6.53 | #Rotatable Bonds: 8 |
Polar Surface Area: 22.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 6.69 | CX LogP: 2.71 | CX LogD: 2.63 |
Aromatic Rings: 4 | Heavy Atoms: 41 | QED Weighted: 0.23 | Np Likeness Score: -0.90 |
1. Long W, Zheng BX, Huang XH, She MT, Liu AL, Zhang K, Wong WL, Lu YJ.. (2021) Molecular Recognition and Imaging of Human Telomeric G-Quadruplex DNA in Live Cells: A Systematic Advancement of Thiazole Orange Scaffold To Enhance Binding Specificity and Inhibition of Gene Expression., 64 (4.0): [PMID:33559473] [10.1021/acs.jmedchem.0c01656] |
Source(1):